Eli Lilly and Company
Pagina dedicata companiei Eli Lilly and Company listata cu simbolul US.LLY
Descriere companie[edit | ]
Eli Lilly and Company (www.lilly.com) is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Ultimele stiri despre Eli Lilly and Company (US.LLY)[edit | ]
- Eli Lilly renunta la testarea unui tratament contra bolii Alzheimer
- Eli Lilly: FDA refuza sa aprobe noul medicament contra bolii Alzheimer
- Biogen: aviz accelerat pentru un nou tratament contra bolii Alzheimer
- Numarul de autoturisme noi inmatriculate - in crestere - 23 octombrie 2023
- BNR a mentinut rata de politica monetara - 09 august 2023
- Agricover deschide balul IPO-urilor de la BVB - 04 mai 2023
- Lilly's (US.LLY) Covid Antibodies Drove A Big Beat, But Omicron Will Limit Sales - 03 februarie 2022
- Eli Lilly: FDA refuza sa aprobe noul medicament contra bolii Alzheimer - 20 ianuarie 2023
- Eli Lilly renunta la testarea unui tratament contra bolii Alzheimer - 09 martie 2023
- Biogen: aviz accelerat pentru un nou tratament contra bolii Alzheimer - 09 ianuarie 2023